Ameritas Investment Partners’s Danimer Scientific, Inc. DNMR Stock Holding History

Ameritas Investment Partners’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$84	–	3160
2024 Q3	$84	Hold	5	–	–	﹤0.01%	3127
2024 Q2	$112	Sell	5 -175	-97%	-$5.44K	﹤0.01%	3117
2024 Q1	$7.83K	Hold	180	–	–	﹤0.01%	2879
2023 Q4	$7.33K	Hold	180	–	–	﹤0.01%	2916
2023 Q3	$14.9K	Hold	180	–	–	﹤0.01%	2663
2023 Q2	$17.1K	Hold	180	–	–	﹤0.01%	2642
2023 Q1	$24.8K	Hold	180	–	–	﹤0.01%	2376
2022 Q4	$16.2K	Buy	180 +5	+3%	+$473	﹤0.01%	2645
2022 Q3	$20K	Hold	175	–	–	﹤0.01%	2535
2022 Q2	$31K	Sell	175 -5	-3%	-$908	﹤0.01%	2299
2022 Q1	$42K	Hold	180	–	–	﹤0.01%	2160
2021 Q4	$61K	Buy	180 +41	+29%	+$22.6K	﹤0.01%	2016
2021 Q3	$91K	Hold	139	–	–	﹤0.01%	1754
2021 Q2	$139K	Buy	139 +134	+2,680%	+$134K	0.01%	1522
2021 Q1	$6K	Buy	+5	New	+$8.12K	﹤0.01%	2988

Other funds holding DNMR

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

SAM

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Ameritas Investment Partners's DNMR Position: Q4 2024 in Review

Ameritas Investment Partners sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 5 shares — an estimated $84 sold.

Ameritas Investment Partners first reported a position in DNMR in Q1 2021 and held it in 15 quarters. The position peaked at $139K in Q2 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

Ameritas Investment Partners reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
Ameritas Investment Partners sold 5 Danimer Scientific, Inc. shares in Q4 2024, an estimated $84.
Ameritas Investment Partners first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 15 quarters.
Ameritas Investment Partners's Danimer Scientific, Inc. position peaked at $139K in Q2 2021.
3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Ameritas Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.